| Biological Information | |
|---|---|
| Background Information: | BAZ2-ICR or 4-[4-(1-Methyl-1H-pyrazole-4-yl)-1-[2-(1-methyl-1H-pyrazol-4-yl)ethyl]-1H-imidazol-5-yl]benzonitrile, is a selective BAZ2 bromodomain inhibitor that exhibits 15-fold selectivity for the BAZ2 bromodomain over the CERC2 bromodomain and >100-fold selectivity over a range of other bromodomains. Provided as 10 mg of dry powder. |
| Target Name: | BAZ2-ICR |
| Usage | |
| Product Type: | Control Ligands & Inhibitors |
| Application: | Drug Discovery & Development |
| Storage Conditions: | Store at -20°C. Please avoid multiple freeze/thaw cycles. |
| Usage Disclaimer: | These products may be covered by issued US and/or foreign patents, patent application and subject to Limited Use Label License. Please visit discoverx.com/license for a list of products that are governed by limited use label license terms and relevant patent and trademark information. |
| Additional Information | |
| Brand: | DiscoverX |
BAZ2-ICR
BAZ2-ICR is an agonist for BAZ2A. This product is provided as 10 mg of dry powder.
Datasheets
92-1308 Datasheet
View Document